vonPawel, J.
8  results:
Search for persons X
?
1

9077 Phase 2 study of pemetrexed and cisplatin plus either ..:

Reck, M. ; Ramlau, R. ; VonPawel, J....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 528 , 2009
 
?
2

9160 Molecular and clinical biomarkers of outcome with cetu..:

O'Byrne, K. ; Pereira, J. Rodrigues ; vonPawel, J....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 553 , 2009
 
?
3

6570 POSTER Results for progression-free survival (PFS) fro..:

Sandler, A. ; Reck, M. ; vonPawel, J....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 379 , 2007
 
?
4

6518 ORAL Subgroup results from a randomised, double-blind,..:

Eberhardt, W. ; Reck, M. ; vonPawel, J....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 362 , 2007
 
?
5

6503 ORAL Efficacy and safety results from BO17704, a rando..:

Manegold, C. ; vonPawel, J. ; Zatloukal, P....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 357 , 2007
 
?
6

6509 ORAL Management of hypertension (HTN) in patients with..:

Bennouna, J. ; vonPawel, J. ; Zatloukal, P....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 359 , 2007
 
?
7

6568 POSTER Phase II trial of the novel epothilone ZK-EPO a..:

Gatzemeier, U. ; vonPawel, J. ; Eschbach, C....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 378 , 2007
 
1-8